Sierra Oncology's Other Investors

Sierra Oncology raised a round of funding on , . Investors include Sigvion Capital.

Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for cancer and other diseases. The compa…

Articles about Sierra Oncology's Other Investors: